| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 03/06/2008 | US20080056994 Assays For Diagnosing And Evaluating Treatment Options For Fabry Disease |
| 03/06/2008 | US20080056993 Post-ischemic myocardial injury; administer a first concurrent parenteral infusion of adenosine and inosine during or following an acute myocardial infarction; protect against reperfusion following ischemic insult in the heart, brain, spinal cord, anti-inflammatory, reduce pain, anesthesia requirements |
| 03/06/2008 | US20080056992 Biological Marker for Inflammation |
| 03/06/2008 | US20080056991 Histamine H3 receptor inhibitors; (4-Azepan-1-ylmethyl-phenyl)-(4-isopropyl-piperazin-1-yl)-methanone dihydrochloride for example; allergies, nasal congestion, eating disorders, sleep disorders, neurodegenerative disorders |
| 03/06/2008 | US20080056989 Polyhydroxy-polysulphonyl-glucose-benz(e)indoles; absorb and fluoresce in visible region; optical diagnosis of renal and cardiac diseases and for estimation of blood volume in vivo; tomography; magnetic resonance imaging; benzoindocarbocyanines |
| 03/06/2008 | CA2646091A1 Compositions for visualization of vitreous body and methods of using same |
| 03/05/2008 | EP1894006A2 Method for identifying modulators of keah6 useful for treating alzheimer's disease |
| 03/05/2008 | EP1893243A2 Contrast agents comprising tungsten-containing cores |
| 03/05/2008 | EP1893242A2 Method for producing albumin conjugates comprising an x-ray contrast medium as the active substance |
| 03/05/2008 | EP1505904A4 Method and apparatus for quantitatively evaluating a kidney |
| 03/05/2008 | EP1064360B1 Luciferases, gfp fluorescent proteins, their nucleic acids and the use thereof in diagnostics |
| 03/05/2008 | CN101137755A Method for gene delivery to neuronal cells |
| 03/05/2008 | CN101137398A Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications |
| 03/05/2008 | CN101137397A Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies |
| 03/05/2008 | CN101135679A Insulinogen C peptide biological activity measuring method |
| 03/05/2008 | CN101133950A Hot plate experimentation on-line automatic detection device |
| 03/04/2008 | US7338664 A sustained-release matrix for dental application includes either an anti-microbial agent or a colorant that is released from the matrix when the matrix contacts water; include a water-soluble polymer and a water-insoluble support resin |
| 03/04/2008 | US7338652 Methods for positron emission imaging with radiolabeled halogenated xanthenes diagnostic agents |
| 03/04/2008 | US7338651 Multi-use multimodal imaging chelates |
| 02/28/2008 | WO2008024694A2 Evaluation of immediate-effect skin molding agents using disc |
| 02/28/2008 | WO2008024114A1 Genemap of the human genes associated with schizophrenia |
| 02/28/2008 | WO2008023305A2 Contrast agent comprising a tm2+ containing luminescent substance for optical imaging |
| 02/28/2008 | WO2008023064A2 Use of a composition for skin treatment during x-ray irradiation |
| 02/28/2008 | WO2007057182A3 Fluorescent nanoparticles |
| 02/28/2008 | WO2007042504A3 Compounds comprising a biological target recognizing part, coupled to a signal part capable of complexing gallium |
| 02/28/2008 | US20080050376 Compositions And Uses Thereof For Identifying And Targeting Provasopressin-Expressing Cancer Cells |
| 02/28/2008 | US20080050313 Sulfs as Modifiers of the Beta-Catenin Pathway and Methods of Use |
| 02/28/2008 | US20080050311 Monoclonal Antibody hPAM4 |
| 02/28/2008 | DE10112470B4 Verfahren zur Proben-Identifizierung bei einem Säugetier sowie Kit zur Durchführung dieses Verfahrens A method for sample identification in a mammal, and kit for performing this method |
| 02/28/2008 | DE10066210B4 Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Plaques Use of perfluoroalkyl-containing metal complexes as contrast agents in MR imaging for presentation of plaques |
| 02/28/2008 | CA2661506A1 Use of a composition for skin treatment under x-irradiation |
| 02/27/2008 | EP1891721A1 Optical irradiation device for the polarization of alkali metal atoms and a device for the hyperpolarization of noble gases |
| 02/27/2008 | EP1558616B1 Meso-substituted porphyrins |
| 02/27/2008 | CN201026205Y Modified type static inhalation exposure cabinet |
| 02/27/2008 | CN101132814A A staining composition for staining an ophthalmic membrane |
| 02/27/2008 | CN101130095A Lipid microvesicle ultrasound angiography powder agent internally containing mixture gas of fluorine carbon/nitrogen gas and production of the same |
| 02/27/2008 | CN101130094A Ultrasonic contrast medium and its preparing process |
| 02/27/2008 | CN101130093A Antisense oligonucleotide probe contrast agent marked by superparamagnetism iron oxide and production of the same |
| 02/27/2008 | CN100371022C Method for establishing anti-hepatitis C virus drug screening experimental animal model |
| 02/26/2008 | US7335684 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 02/26/2008 | US7335652 Introducing into the subject a ligand capable of labelling aggregated paired helical filament (PHF) tau protein, determining the presence and\or amount of ligand bound to extracellular aggregated PHF tau in the medial temporal lobe of the brain, correlating the result of the determination |
| 02/26/2008 | US7335632 Selectively inhibit memapsin 2 beta -secretase activity relative to memapsin 1 beta -secretase activity; Alzheimer's disease |
| 02/26/2008 | US7335369 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 02/26/2008 | CA2463001C Solution based methacholine formulations |
| 02/21/2008 | WO2008021981A2 Local treatment of epidermal and dermal hyperproliferative lesions |
| 02/21/2008 | WO2008020765A2 Imaging medium comprising lactate and hyperpolarised 13c-pyruvate |
| 02/21/2008 | WO2007140410A9 Low-density lipoprotein receptor 6 (lrp6) as a mammary stem cell marker and related methods |
| 02/21/2008 | WO2007100777A3 Methods for the treatment of adhd and related disorders |
| 02/21/2008 | WO2005020898A3 Methods of reducing visceral fat by increasing levels of insulin-like growth factor-i (igf-i) |
| 02/21/2008 | US20080045920 Method Of Constructing Animal Model Suffereing From Left Ventricular Diastolic Disorder For Examining Heart Failure And Method Of Examining Remedy For Heart Failure Caused By Left Ventricular Diastolic Failure With The Use Of The Animal Model |
| 02/21/2008 | US20080045796 Histofluorescent stain composition for endoscopy |
| 02/21/2008 | US20080044859 Fibroblast Growth Factor Receptor-Like Molecules and Uses Thereof |
| 02/21/2008 | US20080044360 Methods of collagen imaging |
| 02/21/2008 | US20080044359 Cell permeable probe |
| 02/21/2008 | US20080044357 Methods And Systems For High Throughput Research Of Ionic Liquids |
| 02/21/2008 | US20080044356 Assemblies of Oligomeric Amyloid Beta Protein and Uses Thereof |
| 02/21/2008 | US20080044355 including cystic fibrosis transmembrane conductance regulator ("CFTR"); amido-phenyl derivatives; genetic disorders; respiratory system disorders, cystic fibrosis, hereditary emphysema, hereditary hemochromatosis, coagulation-fibrinolysis and lipid processing deficiencies, lysosomal storage disease |
| 02/21/2008 | US20080044352 pH-sensing dye/lipoprotein conjugates; high-throughput assays; 2-{[1E,3E,5E)-5-(3-methyl-3-(5-carboxypentyl)-5-sulfo-1,3-dihydro-2H-indol-2-ylidene]-1,3-pentadienyl}-3,3-dimethyl-5-sulfo-1-(4-sulfobutyl)-3H-indolium dye conjugate |
| 02/21/2008 | US20080044351 Method and procedure to detect oral tissues with high-risk molecular profiles |
| 02/21/2008 | US20080044350 Optical Imaging Contrast Agents for Imaging Lung Cancer |
| 02/21/2008 | US20080044348 Tetanus toxin fragment C based imaging agents and methods, and confocal microscopy dataset processes |
| 02/21/2008 | CA2660373A1 Methods and compositions for needleless delivery of particles |
| 02/20/2008 | EP1888124A1 Mri contrast medium containing liposomes |
| 02/20/2008 | EP0986757B1 Method and device for detecting or quantifying carbohydrate containing compounds |
| 02/20/2008 | EP0986309B1 Uses of oil bodies |
| 02/20/2008 | CN101128218A Use of cyanine dyes for the diagnosis of proliferative diseases |
| 02/19/2008 | US7333847 Method for evaluation of tissue adhesion level |
| 02/19/2008 | US7332586 Active agent and a nuclear localization signal and methods of modulating gene expression and protein expression employing the nanoparticle delivery vehicle. A representative method includes providing a nanoparticle delivery vehicle comprising |
| 02/19/2008 | US7332351 Precipitating nano-sized cores from reagents dissolved in the aqueous compartment of a water-in-oil microemulsion; silica coated; as dye-doped particles, "pigmentless" pigment particles, metal particles, semiconductor particles, magnetic particles, and drug molecule particles |
| 02/19/2008 | US7332149 Diagnosis, therapy of cancer, rheumatoid arthritis, for monitoring therapeutic angiogenesis treatment and destruction of new angiogenic vasculature, imaging tumors, atherosclerosis, restenosis, cardiac ischemia, and myocardial reperfusion injury |
| 02/19/2008 | CA2220008C Composition and method for tumor imaging |
| 02/14/2008 | WO2008019159A2 Controlling osteogenesis by inhibition of osteogenic suppressors |
| 02/14/2008 | WO2008019052A2 Methods and compositions for identifying biomarkers |
| 02/14/2008 | WO2008018327A1 Diagnostic agent |
| 02/14/2008 | WO2008017944A2 Composition apparatus and method for use in imaging |
| 02/14/2008 | WO2008017122A1 Polylysine dendrimer contrast agent |
| 02/14/2008 | WO2007145936A9 System and methods for evaluating the efficacy of appetite-affecting drugs |
| 02/14/2008 | WO2007127470A3 Method for the diagnosis and treatment of conditions involving aberrant erythrocyte potassium levels |
| 02/14/2008 | US20080039816 Carbohydrate-Encapsulated Quantum Dots for Bilogical Imaging |
| 02/14/2008 | US20080038202 Controlling osteogenesis by inhibition of osteogenic suppressors |
| 02/14/2008 | US20080038201 Global regulator of morphogenesis and pathogenicity in dimorphic fungi and uses thereof |
| 02/14/2008 | US20080038198 Method Of Screening Molecule Associated With Psychiatric Disorder |
| 02/14/2008 | US20080038197 Method and apparatus for representing myocardial tissues in different states of damage |
| 02/14/2008 | US20080038196 Standardization of botanical products utilizing biological activity as a marker |
| 02/14/2008 | DE102006037724A1 Verwendung von Ascorbinsäurederivaten zur Funktionalisierung von Matrices Use of ascorbic acid for the functionalization of matrices |
| 02/13/2008 | EP1886701A2 Marker composite for medical implants |
| 02/13/2008 | EP1886683A1 Novel PPAR ligands that do not cause fluid retention edema or congestive heart failure |
| 02/13/2008 | EP1886112A2 Methods for measuring the metabolism of neurally derived biomolecules in vivo |
| 02/13/2008 | EP1885817A1 Responsive luminescent lanthanide complexes |
| 02/13/2008 | EP1885721A2 Metal chelates of polyaminocarboxylic macrocyclic derivatives and use thereof in diagnostic imaging |
| 02/13/2008 | EP1670350A4 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| 02/13/2008 | EP1454137B1 Use of a labeled ligand having human cd4 specificity for producing a diagnostic used in the analysis of migration and/or distribution patterns of cell populations |
| 02/13/2008 | CN201019737Y Multi-pass multi-spectrum human body skin tester |
| 02/13/2008 | CN101123996A Compositions and methods for enhancing contrast in imaging |
| 02/13/2008 | CN101123995A Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 02/13/2008 | CN101120921A Target preparation consisting of liposome and nucleic acid coating contrast agent |
| 02/13/2008 | CN100369181C Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 02/12/2008 | US7330748 Method for determining in vivo concentration of a metabolite |
| 02/12/2008 | US7329735 Contains at least one mutation that reduces or eliminates the ability of the fluorescent protein to oligomerize; determining the pH of a sample, presence of an enzyme, and activity of an enzyme by variation of fluorescence; kits |
| 02/12/2008 | US7329644 Preparation and use of cyclic and branched peptides and their labelled derivatives as therapeutic agents, cholecystokinin agonists or antagonists, and diagnostic agents to identify and locate tumours |